TIGRIS PHARMACEUTICALS

Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.

#SimilarOrganizations #People #Financial #Website #More

TIGRIS PHARMACEUTICALS

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2005-01-01

Address:

Bonita Springs, Florida, United States

Country:

United States

Website Url:

http://www.tigrispharma.com

Total Employee:

1+

Status:

Active

Contact:

239.444.5400

Email Addresses:

[email protected]

Total Funding:

32.49 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apache AJAX Libraries API SAKURA Internet

Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

Current Employees Featured

not_available_image

Edmundo Muniz
Edmundo Muniz President & CEO @ Tigris Pharmaceuticals
President & CEO

not_available_image

Anne White
Anne White COO @ Tigris Pharmaceuticals
COO

Founder

mark-pruzanski_image

Mark Pruzanski

Investors List

sonostar-capital-partners_image

Sonostar Capital Partners

Sonostar Capital Partners investment in Series C - Tigris Pharmaceuticals

riverbank-capital-securities_image

Riverbank Capital Securities

Riverbank Capital Securities investment in Series C - Tigris Pharmaceuticals

wexford-capital_image

Wexford Capital

Wexford Capital investment in Series B - Tigris Pharmaceuticals

ngn-capital_image

NGN Capital

NGN Capital investment in Series B - Tigris Pharmaceuticals

riverbank-capital-securities_image

Riverbank Capital Securities

Riverbank Capital Securities investment in Series B - Tigris Pharmaceuticals

Official Site Inspections

http://www.tigrispharma.com

Host Informations
Whois Informations

Loading ...

More informations about "Tigris Pharmaceuticals" on Search Engine